Simple genetic test shows promise for better outcomes in heart stent patients

A quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients, a group led by University of Florida Health researchers has found. The test identifies a genetic deficiency that affects the body’s ability to activate clopidogrel, a common anti-clotting drug given after a coronary artery stent is inserted.

For more details about how genetic information is used to make recommendations for medication choices and doses, visit https://www.pharmgkb.org/view/dosing-guidelines.do?source=CPIC